Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-22-014476

Chief Accounting Officer acquired 4,200 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Weiss Amir · Chief Accounting Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2022-02-28 Exercise or conversion : show line 1 in the form +3,219 17,610.41 D
2022-03-02 Exercise or conversion : show line 2 in the form +981 18,591.41 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-02-28 Exercise or conversion : show line 3 in the form Restricted Share Units −3,219 6,438 D
2022-03-02 Exercise or conversion : show line 4 in the form Restricted Share Units −981 0 D
Loading xslF345X03/doc4.xml…